Dancann Pharma AS (DANCAN)

Spotlight
Currency in DKK
0.0018
0.0000(0.00%)
Real-time Data
DANCAN Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Earnings results expected in 9 days
Fair Value
Day's Range
0.00180.0020
52 wk Range
0.00160.0910
Key Statistics
Edit
Bid/Ask
0.0018 / 0.002
Prev. Close
0.0018
Open
0.002
Day's Range
0.0018-0.002
52 wk Range
0.0016-0.091
Volume
9.26M
Average Volume (3m)
86.12M
1-Year Change
-66.15%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DANCAN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Dancann Pharma AS Company Profile

DanCann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas. It sources, develops, and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients. The company’s development pipeline includes EXT02 CannGros, EXT03 CannGros, EXT04 CannGros, FLS04 CannGros, and FLS05 CannGros. It is also involved in the import and distribution of Bedrocan CannGros, Bedica CannGros, and Bediol CannGros. The company was incorporated in 2018 and is based in Ansager, Denmark.

Compare DANCAN to Peers and Sector

Metrics to compare
DANCAN
Peers
Sector
Relationship
P/E Ratio
−0.1x−1.3x−0.7x
PEG Ratio
0.000.000.00
Price/Book
0.5x2.3x2.6x
Price / LTM Sales
0.9x3.8x3.1x
Upside (Analyst Target)
-219.5%46.7%
Fair Value Upside
Unlock3.4%8.1%Unlock

Earnings

Latest Release
Nov 29, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Dancann Pharma AS (DANCAN) Stock Price Today?

The Dancann Pharma AS stock price today is 0.0018.

What Stock Exchange Does Dancann Pharma AS Trade On?

Dancann Pharma AS is listed and trades on the Spotlight stock exchange.

What Is the Stock Symbol for Dancann Pharma AS?

The stock symbol for Dancann Pharma AS is "DANCAN."

What Is the Dancann Pharma AS Market Cap?

As of today, Dancann Pharma AS market cap is 7.18M.

What is Dancann Pharma AS Earnings Per Share?

The Dancann Pharma AS EPS is -0.047.

What Is the Next Dancann Pharma AS Earnings Date?

Dancann Pharma AS will release its next earnings report on 25 Feb 2025.

From a Technical Analysis Perspective, Is DANCAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.